EGFR and breast cancer: Furthermore, RA-XII was demonstrated to affect the expressions of proteins in PI3K/AKT, NF-κB, FAK/pSRC, MAPK and EGFR signaling pathways, so as to exert its anti-metastatic effects in breast cancer cells.